Johnson & Johnson will appeal $4.7B powder award

Johnson& Johnson says it will "pursue all available appellate remedies" to reverse a St. Louis court verdict that awarded $4.7 billion to women who alleged that using the company ’s baby powder caused their ovarian cancer.  In a prepared statement, J&J (NYSE:JNJ) contends that the lawsuit filed on behalf of 22 women should not have been heard in Missouri because many of the women were not from the state.   Company spokeswoman Carol Goodrich predicted a reversal, saying, “The multiple errors…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news